Pembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma
Clinical trial NCT04550624 · COMPLETED
Trial details
- NCT number
- NCT04550624
- Sponsor
- Shanghai Jiahui International Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2025-07-18
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.